Sleep Disorders

Lois E. Krahn

doi:10.1055/s-2003-814742

Seminars in Neurology, Table of Contents

Semin Neurol 2003; 23(3): 307-314
DOI: 10.1055/s-2003-814742

Sleep Disorders

Lois E. Krahn

Department of Psychiatry & Psychology, Mayo Sleep Disorders Center, Mayo Clinic Scottsdale, Scottsdale, Arizona

Abstract

ABSTRACT

Patients with sleep disorders present with a variety of complaints including excessive daytime sleepiness, daytime spells, inability to sleep, uncomfortable sensation in the extremities, and unusual night time behaviors. This article provides eight vignettes on patients with sleep disorders including narcolepsy, idiopathic hypersomnia, obstructive sleep apnea, restless legs syndrome, and rapid eye movement behavior disorder. The discussion provides data regarding the epidemiology, pathophysiology, and diagnostic approach for these conditions. The various treatment options for these sleep disorders are also identified.

KEYWORDS

Narcolepsy - cataplexy - restless legs - rapid eye movement behavior disorder

Full Text

References

REFERENCES

1 Silber M, Krahn L, Olson E, Pankratz V. Epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep . 2001; 24 A98
2 Krahn L, Boeve B, Olson E, Herold D, Silber M. A standardized test for cataplexy. Sleep Med . 2000; 1 125-130
3 Broughton R, Guberman A, Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia . 1984; 25 423-433
4 Silber M, Krahn L, Olson E, Pankratz V. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep . 2002; 25 197-202
5 Mignot E, Hayduk R, Black J, Grumet F, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep . 1997; 20 1012-1020
6 Chervin R, Dillon J, Bassetti C, Ganoczy D, Pituch K. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep . 1997; 20 1185-1192
7 Krahn L, Hansen M, Shepard J. Pseudocataplexy. Psychosomatics . 2001; 42 356-358
8 Krahn L, Black J, Silber M. Narcolepsy: new understanding of irresistible sleep. Mayo Clin Proc . 2001; 76 185-194
9 Overeem S, Mignot E, Gert van Dijk J, Lammers G. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol . 2001; 18 78-105
10 Black J, Krahn L, Silber M. A pilot study of serologic markers of autoimmunity in patients with narcolepsy. Sleep . 2001; 24 A318-A319
11 Thannickal T, Moore R, Nienhuis R. et al . Reduced number of hypocretin neurons in human narcolepsy. Neuron . 2000; 27 469-474
12 Nishino S, Ripley B, Overeem S, Lammers G, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy (letter). Lancet . 2000; 355 39-40
13 Schuld A, Blum W, Pollmacher T. Low CSF hypocretin (orexin) and altered energy metabolism in human narcolepsy. Ann Neurol . 2002; 51 660-661
14 Mignot E, Lammers G, Ripley B. et al . The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol . 2002; 59 1553-1562
15 Smart D, Jerman J. The physiology and pharmacology of the orexins. Pharmacol Ther . 2002; 94 51-61
16 US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol . 1998; 43 88-97
17 Scharf M, Lai A, Branigan B, Stover R, Berkowitz D. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep . 1998; 21 507-514
18 Zyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep . 2002; 25 42-49
19 Mitler M, Shafor R, Hajdukovich R, Timms R, Browman C. Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline. Sleep . 1986; 9 260-264
20 Billiard M, Merle C, Carlander B, Ondze B, Alvarez D, Besset A. Idiopathic hypersomnia. Psychiatry Clin Neurosci . 1998; 52 125-129
21 Bassetti C, Aldrich M. Idiopathic hypersomnia: a series of 42 patients. Brain . 1997; 120 1423-1435
22 Kanbayashi T, Inque Y, Chiba S. et al . CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res . 2002; 11 91-93
23 Walker R. Long-term health consequences of mild to moderate obstructive sleep apnea. Arch Otolaryngol Head Neck Surg . 2001; 127 1397-1400
24 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med . 1993; 328 1230-1235
25 Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med . 2002; 165 1217-1239
26 Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med . 1995; 1 482-487
27 Rama A, Tekwani S, Kushida C. Sites of obstruction in obstructive sleep apnea. Chest . 2002; 122 1139-1147
28 Dart R, Gregoire J, Gutterman D, Woolf S. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest . 2003; 123 244-260
29 Bananian S, Lehrman S, Maguire G. Cardiovascular consequences of sleep-related breathing disorders. Heart Dis . 2002; 4 296-305
30 Loh N, Dinner D, Foldvary N, Skobieranda F, Yew W. Do patients with obstructive sleep apnea wake up with headaches?. Arch Intern Med . 1999; 159 1765-1768
31 Dodick D, Eross E, Parish J. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. ; 34 282-292
32 Berry R, Parish J, Hartse K. The use of auto-titrating continuous positive airway pressure for the treatment of adult obstructive sleep apnea: an American Academy of Sleep Medicine review. Sleep . 2002; 25 148-173
33 Sullivan C, Grunstein R. Continuous positive airway pressure in sleep-disordered breathing. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine 2nd ed. Philadelphia: WB Saunders 1994: 694
34 Clark G, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficiency of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest . 1996; 109 1477-1483
35 Flemons W. Obstructive sleep apnea. N Engl J Med . 2002; 347 498-504
36 Lojander P, Maasilta P, Partinen M, Brander P, Salmi T, Lehtonen H. Nasal-CPAP and conservative management for treatment of obstructive sleep apnea syndrome: a randomized study. Chest . 1996; 110 114-119
37 Littner M, Kushida C, Hartse K. et al . Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. Sleep . 2001; 24 603-619
38 Berry R, Deas M, Light R. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest . 1991; 99 339-341
39 Dolly F, Block A. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med . 1982; 73 239-243
40 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients with new standard criteria. Move Disord . 1997; 12 61-65
41 Chaudhuri K, Appiah-Kubi L, Trenkwalder C. Restless legs syndrome. J Neurol Neurosurg Psychiatry . 2001; 71 143-146
42 Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. J Clin Neurophysiol . 1999; 110 1168-1174
43 Phillips B, Young T, Finn L, Asher K, Hening W, Purvis C. Epidemiology of restless legs syndrome in adults. Arch Intern Med . 2000; 160 2137-2141
44 Ohayon M, Roth T. Prevalence of restless legs syndrome and periodic movement disorder in the general population. J Psychosom Res . 2002; 53 547-554
45 Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau G. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet . 2001; 69 1266-1270
46 Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain . 2003; 126 1485-1492
47 Winkelmann J, Chertow G, Lazarus J. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis . 1996; 28 372-378
48 Takaki J, Nishi T, Nangaku M. et al . Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis . 2003; 41 833-839
49 Ruottinen H, Partinen M, Hublin C. et al . An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology . 2000; 54 502-504
50 Earley C, Allen R, Beard J, Connor J. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res . 2000; 62 623-628
51 Allen R, Earley C. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol . 2001; 18 128-147
52 Comella C. Restless legs syndrome: treatment with dopaminergic agents. Neurology . 2002; 58 S87-S92
53 Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci . 2002; 252 185-194
54 Pritchett A, Morrison J, Edwards W D, Schaff H, Connolly H, Espinosa R. Valvular heart disease in patients taking pergolide. Mayo Clin Proc . 2002; 77 1280-1286
55 Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology . 2002; 59 1573-1579
56 Walters A, Winkelmann J, Trenkwalder C. et al . Long-term follow-up on restless legs syndrome patients treated with opioids. Move Disord . 2001; 16 1105-1109
57 Davis B, Rajput A, Rajput M, Aul E, Eichhorn G. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol . 2000; 43 70-75
58 Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep . 1986; 9 293-308
59 Schenck C, Hurwitz T, Mahowald M. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. Sleep . 1993; 2 224-231
60 Olson E, Boeve B, Silber M. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain . 2000; 123 331-339
61 Schenck C, Mahowald M, Kim S, O'Connor K, Hurwitz T. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep . 1992; 15 226-235
62 Comella C, Nardine T, Diedrich N, Stebbins G. Sleep-related violence, injuries and REM behavior disorder in Parkinson's disease. Neurology . 1998; 51 526-529
63 Plazzi G, Corsini R, Provini F. et al . REM behavior disorder in multiple system atrophy. Neurology . 1997; 48 1094-1097
64 Boeve B, Silber M, Ferman T, Lucas J, Parisi J. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Move Disord . 2001; 16 622-630
65 Schenck C, Mahowald M. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med . 1996; 100 333-337